Lv11
24 积分 2025-09-06 加入
Multi-target incretin-based therapeutics: The rise of dual and triple agonists for metabolic disorders
2小时前
已完结
Retatrutide improves steatohepatitis in an accelerated mouse model of diet-induced steatohepatitis with a fructose binge
2小时前
已完结
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2小时前
已完结
Successful Treatment of Hepatitis B Virus-associated Membranous Nephropathy with Entecavir and Immunosuppressive Agents
5天前
已完结
Biocompatible and biodegradable copper-protocatechuic metal-organic frameworks as rifampicin carrier
8天前
已完结
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists
27天前
已完结
Review Article: GLP‐1 Receptor Agonists and Glucagon/GIP/GLP‐1 Receptor Dual or Triple Agonists—Mechanism of Action and Emerging Therapeutic Landscape in MASLD
27天前
已完结
The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors
1个月前
已完结
皖公网安备34019202002308
